If you're a woman starting a GLP-1 medication, you probably have questions that go beyond the number on the scale. Will your periods change? Could this affect your birth control? What if you want to get pregnant someday? We hear these questions often in our practice, and they deserve clear, careful answers.
GLP-1 and women's health: the short version
GLP-1 medications were designed to manage type 2 diabetes and obesity, and they also affect reproductive health in women of childbearing age. Weight loss can change your menstrual cycle, it can affect fertility, and certain GLP-1 medications may interact with the birth control pill. None of this should scare you off treatment. Raise these topics with your prescriber early.
This article is educational and isn't a substitute for personalized medical advice. Dr. Tran Le, MD, DABOM, leads our program. She is triple board-certified in Obesity Medicine, Addiction Medicine, and Occupational and Environmental Medicine. We cover these reproductive considerations from the first visit.
How GLP-1 medications can change your periods
Excess weight and insulin resistance disrupt the hormonal signaling that drives a regular cycle. Obese women undergo perturbations of the hypothalamic-pituitary-ovarian axis, and frequently suffer menstrual dysfunction leading to anovulation and infertility. In adult women, most studies report a prevalence of menstrual cycle irregularities in women with obesity of 30% to 36%.
This can improve. Weight loss programs through lifestyle modification in obese women have been proven to restore menstrual cyclicity and ovulation and improve the likelihood of conception.
The American Society for Reproductive Medicine notes that improved ovulation rates and menstrual regularity have been demonstrated with modest weight loss through lifestyle modification, with and without adjunctive weight loss medications, in women with PCOS.
Some women notice their cycles becoming more regular, or returning after a long absence, as they lose weight on a GLP-1. Period changes are a real and expected part of metabolic improvement.
GLP-1 medications, PCOS, and fertility
Polycystic ovary syndrome is the most common hormonal disorder in reproductive-age women and a leading cause of ovulatory infertility. Insulin resistance and weight sit at the center of PCOS, so GLP-1 therapy is being studied closely here.
A scoping review found that GLP-1 receptor agonist use demonstrated promising clinical outcomes for women with PCOS, including reduced BMI, improved metabolic parameters, menstrual regularity, and increased rates of natural pregnancy.
A broader review of the evidence concluded that fertility outcomes may improve with GLP-1RAs and dual GLP-1/GIP agonists due to weight loss and related metabolic benefits.
For PCOS, the literature has long pointed to a modest threshold. Although the optimal degree of weight loss to restore ovulatory function is not clear, at least 5 to 10% weight loss is generally recommended.
This is the mechanism behind the so-called "Ozempic babies" stories. GLP-1 medications aren't fertility drugs. By improving weight, insulin sensitivity, and ovulation, they can make pregnancy more likely in women who previously struggled to conceive. The research base is still growing, and much of it focuses on women with PCOS, so we counsel patients accordingly.
See our medications page for the options we prescribe, including compounded semaglutide and tirzepatide.
Birth control and GLP-1 medications
Some GLP-1 medications can affect how the oral contraceptive pill works. The effect differs by medication.
GLP-1 medicines slow stomach emptying, which makes people feel fuller, longer. Oral medications are released into the body with the same delay. The published evidence shows this matters most for one drug: while tirzepatide has been shown to impact absorption of oral contraceptives due to delayed gastric emptying, other GLP-1 receptor agonists do not appear to have clinically significant interactions with oral contraception.
Because of this, the manufacturer of tirzepatide advises a specific precaution. Due to risks for decreased bioavailability of birth control pills, the manufacturer of Mounjaro (tirzepatide) recommends that patients either use barrier contraception for four weeks after initiation or after a dose increase, or switch to a non-oral contraceptive.
The effect on birth control pills is most pronounced during dose adjustments. Nausea and vomiting from these medications may also cause a woman to lose a dose without realizing it.
Non-oral contraceptives (like the IUD, implant, patch, or condoms) do not appear to be affected by GLP-1 use. If pregnancy isn't your goal right now, raise this at your consult so we can build a plan that fits you. Read more on our tirzepatide and semaglutide pages.
Planning a pregnancy on a GLP-1
GLP-1 medications are not used during pregnancy. For semaglutide, the FDA-approved labeling is explicit: providers should discontinue semaglutide in women at least 2 months before a planned pregnancy due to the long washout period for semaglutide. The drug clears slowly. Semaglutide is dosed weekly because of its roughly one-week half-life, so it lingers for weeks after a final dose.
If you become pregnant unexpectedly while on a GLP-1, stop the medication and contact your OB-GYN and your prescriber promptly. GLP-1 therapy can improve fertility, so an unplanned pregnancy is possible.
Compounded semaglutide and tirzepatide are not FDA-approved, and the same pregnancy precautions and clinical caution apply. See how it works for how we handle this.
Frequently asked questions
Will a GLP-1 make my periods regular again?
It might. Weight loss has been shown to restore menstrual regularity and ovulation in many women, especially those with obesity or PCOS. Everyone's body is different, so we monitor your response individually and cannot promise a specific outcome.
Does my birth control pill still work on a GLP-1?
It depends on the medication. The strongest evidence for reduced pill absorption is with tirzepatide, where backup contraception is advised when starting and after dose increases. Non-oral methods like IUDs, implants, the patch, and condoms aren't affected. Talk with your prescriber about what fits you.
Can I take a GLP-1 if I'm trying to get pregnant?
No. Semaglutide labeling recommends stopping at least two months before a planned pregnancy, and the medication isn't used during pregnancy. If conception is on your horizon, we'll help you plan the timing of your last dose.
Talk it through with a physician-led team
Dr. Le leads our Texas and Utah telehealth program. We address periods, contraception, and pregnancy planning from the start of your care. To weigh your options, start a consultation and we'll make a plan that fits your body and your goals. You can also review our pricing.
Sources
- GLP-1 Receptor Agonists and Reproductive Health: Current Evidence and Clinical Implications (PubMed)
- Clinical Effects of GLP-1 Agonist Use for Weight Loss in Women With PCOS: A Scoping Review (NIH/PMC)
- Obesity as Disruptor of the Female Fertility (Reproductive Biology and Endocrinology)
- Resumption of Ovulation in Anovulatory Women With PCOS and Obesity (Human Reproduction, Oxford Academic)
- Obesity and Reproduction: A Committee Opinion, 2021 (American Society for Reproductive Medicine)
- How GLP-1 Drugs Can Affect Fertility and Birth Control (University Hospitals)
- OZEMPIC (semaglutide) Prescribing Information (FDA)